HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1-mutant lung cancer.

Abstract
The LKB1/STK11 tumor suppressor encodes a serine/threonine kinase, which coordinates cell growth, polarity, motility, and metabolism. In non-small cell lung carcinoma, LKB1 is somatically inactivated in 25% to 30% of cases, often concurrently with activating KRAS mutations. Here, we used an integrative approach to define novel therapeutic targets in KRAS-driven LKB1-mutant lung cancers. High-throughput RNA interference screens in lung cancer cell lines from genetically engineered mouse models driven by activated KRAS with or without coincident Lkb1 deletion led to the identification of Dtymk, encoding deoxythymidylate kinase (DTYMK), which catalyzes dTTP biosynthesis, as synthetically lethal with Lkb1 deficiency in mouse and human lung cancer lines. Global metabolite profiling showed that Lkb1-null cells had a striking decrease in multiple nucleotide metabolites as compared with the Lkb1-wild-type cells. Thus, LKB1-mutant lung cancers have deficits in nucleotide metabolism that confer hypersensitivity to DTYMK inhibition, suggesting that DTYMK is a potential therapeutic target in this aggressive subset of tumors.
AuthorsYan Liu, Kevin Marks, Glenn S Cowley, Julian Carretero, Qingsong Liu, Thomas J F Nieland, Chunxiao Xu, Travis J Cohoon, Peng Gao, Yong Zhang, Zhao Chen, Abigail B Altabef, Jeremy H Tchaicha, Xiaoxu Wang, Sung Choe, Edward M Driggers, Jianming Zhang, Sean T Bailey, Norman E Sharpless, D Neil Hayes, Nirali M Patel, Pasi A Janne, Nabeel Bardeesy, Jeffrey A Engelman, Brendan D Manning, Reuben J Shaw, John M Asara, Ralph Scully, Alec Kimmelman, Lauren A Byers, Don L Gibbons, Ignacio I Wistuba, John V Heymach, David J Kwiatkowski, William Y Kim, Andrew L Kung, Nathanael S Gray, David E Root, Lewis C Cantley, Kwok-Kin Wong
JournalCancer discovery (Cancer Discov) Vol. 3 Issue 8 Pg. 870-9 (Aug 2013) ISSN: 2159-8290 [Electronic] United States
PMID23715154 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Thymine Nucleotides
  • Protein Serine-Threonine Kinases
  • STK11 protein, human
  • Stk11 protein, mouse
  • AMP-Activated Protein Kinase Kinases
  • AMP-Activated Protein Kinases
  • Nucleoside-Phosphate Kinase
  • dTMP kinase
  • Hras protein, mouse
  • Proto-Oncogene Proteins p21(ras)
  • thymidine 5'-triphosphate
Topics
  • AMP-Activated Protein Kinase Kinases
  • AMP-Activated Protein Kinases
  • Animals
  • Carcinoma, Non-Small-Cell Lung (drug therapy, genetics, metabolism)
  • Cell Death
  • Cell Line, Tumor
  • DNA Damage
  • DNA Replication
  • Gene Knockdown Techniques
  • Genomics
  • High-Throughput Screening Assays
  • Humans
  • Lung Neoplasms (drug therapy, genetics, metabolism, pathology)
  • Metabolomics
  • Mice
  • Models, Genetic
  • Molecular Targeted Therapy
  • Nucleoside-Phosphate Kinase (genetics, metabolism)
  • Protein Serine-Threonine Kinases (genetics, metabolism)
  • Proto-Oncogene Proteins p21(ras) (genetics, metabolism)
  • RNA Interference
  • Thymine Nucleotides (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: